181 related articles for article (PubMed ID: 29785620)
1. How asymptomatic are early cancer patients of five organs based on registry data in Japan.
Nakabayashi N; Hirose M; Suzuki R; Suzumiya J; Igawa M
Int J Clin Oncol; 2018 Oct; 23(5):999-1006. PubMed ID: 29785620
[TBL] [Abstract][Full Text] [Related]
2. Cancer screening participation in schizophrenic outpatients and the influence of their functional disability on the screening rate: A cross-sectional study in Japan.
Fujiwara M; Inagaki M; Nakaya N; Fujimori M; Higuchi Y; Hayashibara C; So R; Kakeda K; Kodama M; Uchitomi Y; Yamada N
Psychiatry Clin Neurosci; 2017 Dec; 71(12):813-825. PubMed ID: 28875514
[TBL] [Abstract][Full Text] [Related]
3. Trends in clinical stage distribution and screening detection of cancer in Osaka, Japan: Stomach, colorectum, lung, breast and cervix.
Toyoda Y; Tabuchi T; Hama H; Morishima T; Miyashiro I
PLoS One; 2020; 15(12):e0244644. PubMed ID: 33382821
[TBL] [Abstract][Full Text] [Related]
4. Disparities in stage at diagnosis for five common cancers in China: a multicentre, hospital-based, observational study.
Zeng H; Ran X; An L; Zheng R; Zhang S; Ji JS; Zhang Y; Chen W; Wei W; He J;
Lancet Public Health; 2021 Dec; 6(12):e877-e887. PubMed ID: 34838194
[TBL] [Abstract][Full Text] [Related]
5. Association of Socioeconomic Status Assessed by Areal Deprivation With Cancer Incidence and Detection by Screening in Miyagi, Japan Between 2005 and 2010.
Kaneko N; Nishino Y; Ito Y; Nakaya T; Kanemura S
J Epidemiol; 2023 Oct; 33(10):521-530. PubMed ID: 35851564
[TBL] [Abstract][Full Text] [Related]
6. Increasing trends in the prevalence of prior cancer in newly diagnosed lung, stomach, colorectal, breast, cervical, and corpus uterine cancer patients: a population-based study.
Sato A; Matsubayashi K; Morishima T; Nakata K; Kawakami K; Miyashiro I
BMC Cancer; 2021 Mar; 21(1):264. PubMed ID: 33691661
[TBL] [Abstract][Full Text] [Related]
7. Difference of stage at cancer diagnosis by socioeconomic status for four target cancers of the National Cancer Screening Program in Korea: Results from the Gwangju and Jeonnam cancer registries.
Kweon SS; Kim MG; Kang MR; Shin MH; Choi JS
J Epidemiol; 2017 Jul; 27(7):299-304. PubMed ID: 28279589
[TBL] [Abstract][Full Text] [Related]
8. [Report of Cancer Incidence and Mortality in China, 2014].
Chen WQ; Li H; Sun KX; Zheng RS; Zhang SW; Zeng HM; Zou XN; Gu XY; He J
Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):5-13. PubMed ID: 29365411
[No Abstract] [Full Text] [Related]
9. A population-based survey of self-reported delays in breast, cervical, colorectal and lung cancer screening.
Gunn CM; Berrian K; Weiss JE; Tosteson AAN; Hasson RM; Di Florio-Alexander R; Peacock JL; Rees JR
Prev Med; 2023 Oct; 175():107649. PubMed ID: 37517458
[TBL] [Abstract][Full Text] [Related]
10. Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium.
Tosteson AN; Beaber EF; Tiro J; Kim J; McCarthy AM; Quinn VP; Doria-Rose VP; Wheeler CM; Barlow WE; Bronson M; Garcia M; Corley DA; Haas JS; Halm EA; Kamineni A; Rutter CM; Tosteson TD; Trentham-Dietz A; Weaver DL;
J Gen Intern Med; 2016 Apr; 31(4):372-9. PubMed ID: 26658934
[TBL] [Abstract][Full Text] [Related]
11. Cancer screening status in Korea, 2011: results from the Korean National Cancer Screening Survey.
Park B; Choi KS; Lee YY; Jun JK; Seo HG
Asian Pac J Cancer Prev; 2012; 13(4):1187-91. PubMed ID: 22799303
[TBL] [Abstract][Full Text] [Related]
12. The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea.
Park H; Seo SH; Park JH; Yoo SH; Keam B; Shin A
Epidemiol Health; 2022; 44():e2022053. PubMed ID: 35760396
[TBL] [Abstract][Full Text] [Related]
13. Cancer in Canada: Stage at diagnosis.
Bryan S; Masoud H; Weir HK; Woods R; Lockwood G; Smith L; Brierley J; Gospodarowicz M; Badets N
Health Rep; 2018 Dec; 29(12):21-25. PubMed ID: 30566206
[TBL] [Abstract][Full Text] [Related]
14. Site-specific patterns of early-stage cancer diagnosis during the COVID-19 pandemic.
Kinslow CJ; DeStephano DM; Neugut AI; Taparra K; Horowitz DP; Yu JB; Cheng SK
JNCI Cancer Spectr; 2024 Apr; 8(3):. PubMed ID: 38521544
[TBL] [Abstract][Full Text] [Related]
15. The diffusion of screening programmes in Italy, year 2009.
Zappa M; Dardanoni G; Giorgi Rossi P; Grazzini G; Naldoni C; Paci E; Pirola ME; Pizzuti R; Segnan N; Zorzi M; Federici A
Epidemiol Prev; 2011; 35(5-6 Suppl 5):3-7. PubMed ID: 22166346
[TBL] [Abstract][Full Text] [Related]
16. Japanese cancer screening programs during the COVID-19 pandemic: Changes in participation between 2017-2020.
Machii R; Takahashi H
Cancer Epidemiol; 2023 Feb; 82():102313. PubMed ID: 36508964
[TBL] [Abstract][Full Text] [Related]
17. Cancer screening in the primary care setting: the role of the primary care physician in screening for breast, cervical, colorectal, lung, ovarian, and prostate cancers.
Miser WF
Prim Care; 2007 Mar; 34(1):137-67. PubMed ID: 17481991
[No Abstract] [Full Text] [Related]
18. Effectiveness of cervical cancer screening based on a mathematical screening model using data from the Hiroshima Prefecture Cancer Registry.
Ito K; Tsunematsu M; Satoh K; Kakehashi M; Nagata Y
Asian Pac J Cancer Prev; 2013; 14(8):4897-902. PubMed ID: 24083688
[TBL] [Abstract][Full Text] [Related]
19. Identifying incident colorectal and lung cancer cases in health service utilisation databases in Australia: a validation study.
Goldsbury D; Weber M; Yap S; Banks E; O'Connell DL; Canfell K
BMC Med Inform Decis Mak; 2017 Feb; 17(1):23. PubMed ID: 28241763
[TBL] [Abstract][Full Text] [Related]
20. [A report of five cancer screening rates and the related measures for cancer control in the workplace, surveyed by the Corporate Action to Promote Cancer Control].
Minamitani M; Mukai T; Tatemichi M; Katano A; Fukuyoshi J; Nakagawa K
Sangyo Eiseigaku Zasshi; 2023 Sep; 65(5):231-247. PubMed ID: 36967124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
